From Surface to Serious: Key Takeaways on SVT and DVT Management in Primary Care

Primary care providers frequently encounter patients with leg pain, swelling, superficial venous thrombosis (SVT), and suspected deep vein thrombosis (DVT). During a recent Alethea Learning Session, Dr. Luke Rannelli, MD, MSc, FRCPC, provided a practical overview of how to approach SVT and DVT in primary care, with a focus on risk stratification, anticoagulation, recurrence, thrombophilia testing, and long-term complications.

SVT Is Not Always Benign

One of the major themes of the session was that SVT should not automatically be dismissed as minor disease. Clinical significance depends largely on:

• Clot length
• Proximity to the deep venous system
• Recurrence
• Associated varicose veins
• Underlying risk factors

SVTs greater than 5 cm or near the saphenofemoral junction may warrant anticoagulation. Recurrent or migratory SVTs should prompt consideration of broader systemic causes, including occult malignancy.

Repeat Ultrasounds Require Clinical Intent

Dr. Rannelli emphasized that repeat ultrasounds should only be ordered if results are expected to change management. Residual clot on imaging does not necessarily indicate treatment failure or recurrent DVT.

Many patients continue to show chronic clot or venous abnormalities after appropriate treatment. Repeat imaging should focus on distinguishing:

• Acute versus chronic clot
• Evidence of progression
• New thrombosis

The presence of residual clot may instead reflect increased risk for post-thrombotic syndrome.

Thrombophilia Testing Should Be Selective

A key discussion point was the overuse of thrombophilia testing. In many cases, testing:

• Does not change management
• Creates patient anxiety
• Leads to unnecessary investigations
• Has insurance and employment implications

Selective testing may still be appropriate in cases such as:

• Recurrent unprovoked VTE
• Unusual clot locations
• Strong family history
• Recurrent pregnancy loss
• Suspected antiphospholipid syndrome

Routine thrombophilia workup following provoked or oral contraceptive-associated VTE is generally not recommended.

Oral Contraceptives and VTE Risk

Although estrogen-containing contraceptives increase relative VTE risk, the absolute risk remains low in younger healthy patients. Patients who develop VTE while taking oral contraceptives should generally discontinue estrogen-containing therapy and discuss alternative contraceptive options.

Occult Malignancy and Unprovoked VTE

Dr. Rannelli reviewed the relationship between unprovoked VTE and occult cancer, emphasizing that routine “pan-scanning” is not recommended for all patients.

Instead, clinicians should:

• Ensure age-appropriate cancer screening is current
• Assess for constitutional symptoms
• Use clinical judgment when deciding on further investigation

Red flags include unexplained weight loss, recurrent thrombosis, and systemic symptoms.

Post-Thrombotic Syndrome

Post-thrombotic syndrome (PTS) remains a common long-term complication following DVT and may present with:

• Chronic swelling
• Heaviness
• Skin discoloration
• Venous ulceration in severe cases

Although compression stockings are commonly used, evidence for prevention remains limited. Current management focuses primarily on:

• Exercise
• Walking programs
• Calf muscle strengthening
• Avoiding prolonged immobility

Emerging evidence regarding iliac vein stenting for severe PTS was also discussed.

Aspirin Is Not a Substitute for Anticoagulation

Dr. Rannelli clarified that aspirin has a limited role in thrombosis prevention and should not be considered equivalent to anticoagulation for VTE prevention.

Key Takeaways for Primary Care

Throughout the session, Dr. Rannelli emphasized practical, evidence-based decision-making, including:

• Using D-dimer appropriately
• Avoiding unnecessary repeat ultrasounds
• Focusing on recurrence risk rather than clot “resolution”
• Being selective with thrombophilia testing
• Maintaining appropriate cancer screening vigilance

The session reinforced the importance of thoughtful clinical assessment when managing thrombotic disease in primary care settings.

Click here to access the full learning session notes. Alethea users can request the session recording by emailing sales@aletheamedical.com

Not registered on Alethea? Sign up to access learning sessions, eConsults, and specialist collaboration tools designed to support high-quality, connected care.